Skip to main content
Charles River LaboratoriesPatent grant

Charles River Laboratories was granted a patent for antigen-screening methods.

Source: Autobound Signal API · 38 signals tracked for Charles River Laboratories · updated

Get Charles River Laboratories' live signals in Claude or ChatGPT, or by API

AskWhat changed at Charles River Laboratories this week? Use Autobound signals for crl.com.

What happened

In November 2026 Charles River Laboratories patented a cell-library screening approach for finding antigen-responsive binding molecules and chimeric antigen receptors in biomedical research.

Source

patents.google.comNov 17, 2026

US patent US12799628

Antigen binding molecules and methods of screening thereof

Abstract

Described herein are methods of generating a library of cells expressing a plurality of polypeptides or recombinant polypeptides activated by an antigen and methods of panning said library of cells against a target antigen. The methods can be utilized for screening a library of chimeric antigen receptors reactive to a target antigen.

patents.google.com/patent/US12799628Read the full source

Extracted by Autobound

From the Signal API record
Signal
Patent grant

What this signalsA new patent often shows where a company is putting its R&D budget.

Domain
via criver.com
Grant date
Nov 17, 2026
Inventors
Jacob Glanville, Sawsan Youssef
Patent number
US12799628

The full record

From the Signal API record

People

  • Jacob GlanvilleInventor
  • Sawsan YoussefInventor

Details

Primary CPC class
C40B 30/04
USPTO assignee
Charles River Laboratories, Inc.
What the invention does
A method for creating many engineered cells, exposing them to a chosen antigen, and selecting the cells whose receptors respond to it.

Topics and mentions

Tags

  • Intellectual Property
  • Research & Development
  • Bioengineering
  • Medical Research

Technologies named

  • antigen screening
  • cell libraries
  • chimeric antigen receptors
  • recombinant proteins

Extraction

Detected
Nov 18, 2026
signal_type
patents-company
signal_subtype
patentGrant

Use this data

Get every patent signal for Charles River Laboratories and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Charles River Laboratories this week?”

  2. Send it to your own tools

    The Signal API returns patent signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full patents-company record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/03373570-5512-5014-ad1b-dcbade3c97cf returns this record as JSON. POST /v1/companies/enrich returns every signal for crl.com.

{
  "signal_id": "03373570-5512-5014-ad1b-dcbade3c97cf",
  "signal_type": "patents-company",
  "signal_subtype": "patentGrant",
  "detected_at": "2026-11-18T15:12:16+00:00",
  "company": {
    "name": "Charles River Laboratories",
    "domain": "criver.com"
  },
  "data": {
    "cpc": [
      {
        "code": "C40B 30/04"
      },
      {
        "code": "C12N 15/1065"
      },
      {
        "code": "C12N 15/1086"
      }
    ],
    "tags": [
      "Intellectual Property",
      "Research & Development",
      "Bioengineering",
      "Medical Research"
    ],
    "detail": "In November 2026 Charles River Laboratories patented a cell-library screening approach for finding antigen-responsive binding molecules and chimeric antigen receptors in biomedical research.",
    "summary": "Charles River Laboratories was granted a patent for antigen-screening methods.",
    "event_at": "2026-11-17",
    "inventors": [
      {
        "name": "Jacob Glanville",
        "status": "unresolved",
        "is_primary": true
      },
      {
        "name": "Sawsan Youssef",
        "status": "unresolved",
        "is_primary": false
      }
    ],
    "event_kind": "grant_date",
    "grant_date": "2026-11-17",
    "source_url": "https://patents.google.com/patent/US12799628",
    "cpc_primary": {
      "code": "C40B 30/04"
    },
    "patent_title": "Antigen binding molecules and methods of screening thereof",
    "patent_number": "US12799628",
    "uspto_assignee": "Charles River Laboratories, Inc.",
    "patent_abstract": "Described herein are methods of generating a library of cells expressing a plurality of polypeptides or recombinant polypeptides activated by an antigen and methods of panning said library of cells against a target antigen. The methods can be utilized for screening a library of chimeric antigen receptors reactive to a target antigen.",
    "precision_class": "structural",
    "invention_explanation": "A method for creating many engineered cells, exposing them to a chosen antigen, and selecting the cells whose receptors respond to it.",
    "technologies_mentioned": [
      "antigen screening",
      "cell libraries",
      "chimeric antigen receptors",
      "recombinant proteins"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.